Octreotide Microspheres for Preventing Pancreatic Fistula

Summary

This study is a randomized, double-blind, placebo-controlled, multicenter phase III clinical trial designed to evaluate the efficacy and safety of octreotide microspheres in preventing pancreatic fistula after distal pancreatectomy.

Timeline

Start

2026-04-01

Primary completion

2027-12-31

Completion

2028-12-31

Drugs

Indications